Molecular imaging, including single-photon emission computer tomography (SPECT) and fluorescence molecular imaging, has emerged as an advanced approach for predicting the therapeutic efficacy of anti-TNF therapy in IBD with high specificity at the cellular and subcellular levels(Atreya et al. 2014; Brande et al. 2007). This evidence concerns the gene TNF and inflammatory bowel disease.